Skip to main content

Table 1 Characteristics of the participants in the cross-sectional study by phenotype

From: Hypertriglyceridemic waist phenotype and risk of chronic kidney disease in community-dwelling adults aged 60 years and older in Tianjin, China: a 7-year cohort study

Variables

Overall

NWNT

EWNT

NWET

HTGW

P value

(n = 1605)

(n = 552)

(n = 423)

(n = 191)

(n = 439)

Age (years)

67.26 ± 5.94

67.85 ± 6.13

67.74 ± 6.23

66.45 ± 5.60 *

66.39 ± 5.38 *#

< 0.001

Male (%)

708 (44.11%)

323 (58.51%)

238 (56.26%)

40 (20.94%) *#

107 (24.37%) *#

< 0.001

BMI (kg/m2)

25.03 ± 3.51

22.31 ± 2.55

27.00 ± 2.92 *

23.44 ± 2.16 *#

27.24 ± 2.74

< 0.001

WC (cm)

87.05 ± 8.94

79.46 ± 5.97

93.75 ± 5.74 *

80.35 ± 4.70 #

93.05 ± 5.92

< 0.001

SBP (mmHg)

138.54 ± 19.08

136.44 ± 18.70

141.11 ± 17.82 *

136.79 ± 21.98 #

139.45 ± 19.07 *

0.001

DBP (mmHg)

82.35 ± 9.82

81.49 ± 9.95

84.10 ± 9.84 *

81.55 ± 9.78 #

82.09 ± 9.44 #

< 0.001

FPG (mmol/L)

5.26 ± 1.36

5.00 ± 1.11

5.27 ± 1.18 *

5.22 ± 1.36

5.60 ± 1.69 *#§

< 0.001

TC (mmol/L)

5.21 ± 0.97

5.00 ± 0.93

5.04 ± 0.92

5.55 ± 0.87 *#

5.50 ± 0.99 *#

< 0.001

TG (mmol/L)

1.72 ± 1.09

1.08 ± 0.35

1.22 ± 0.34 *

2.37 ± 0.99 *#

2.72 ± 1.30 *#

< 0.001

BUN (mmol/L)

6.08 ± 2.64

6.14 ± 2.22

6.16 ± 2.88

5.67 ± 1.59 *#

6.11 ± 3.19

0.151

Scr (mmol/L)

78.73 ± 12.79

79.21 ± 11.81

79.76 ± 13.16

76.97 ± 11.70 *#

77.91 ± 13.95 #

0.030

eGFR (ml/min/1.73m2)

85.82 ± 14.29

87.65 ± 13.36

86.86 ± 14.85

83.40 ± 12.51 *#

83.58 ± 15.17 *#

< 0.001

ACR (mg/g)

15.33 (8.31 ~ 36.32)

13.23 (7.54 ~ 29.89)

14.16 (7.95 ~ 32.65)

18.38 (9.79 ~ 43.38) *

19.56 (9.87 ~ 49.62) *#

< 0.001

Current smoking (%)

613 (38.19%)

247 (44.75%)

137 (32.39%) *

74 (38.74%)

155 (35.31%) *

< 0.001

Current drinking (%)

381 (23.74%)

167 (30.25%)

142 (33.57%)

17 (8.90%) *#

55 (12.53%) *#

< 0.001

High-salt diet (%)

564 (35.14%)

198 (35.87%)

143 (33.81%)

64 (33.51%)

159 (36.22%)

0.824

Regular exercise (%)

957 (59.63%)

339 (61.41%)

253 (59.81%)

111 (58.12%)

254 (57.86%)

0.685

Hypertension (%)

912 (56.82%)

251 (45.47%)

263 (62.17%) *

112 (58.64%) *

286 (65.15%) *

< 0.001

Antihypertensive treatment (%)

891 (55.51%)

241 (43.66%)

257 (60.76%) *

110 (57.59%) *

283 (64.46%) *

< 0.001

Diabetes (%)

211 (13.15%)

46 (8.33%)

56 (13.24%)

25 (13.09%)

84 (19.13%) *

< 0.001

Antidiabetic therapy (%)

194 (12.09%)

44 (7.97%)

49 (11.58%)

22 (11.52%)

79 (18.00%) *#

< 0.001

  1. Abbreviations: NWNT Normal waist-normal triglycerides; EWNT Elevated waist-normal triglycerides; NWET Normal waist-elevated triglycerides; HTGW Hypertriglyceridemic waist; BMI Body mass index; WC Waist circumference; SBP Systolic blood pressure; DBP Diastolic blood pressure; FPG Fasting plasma glucose; TC Total cholesterol; TG Triglycerides; BUN Blood urea nitrogen; Scr Serum creatinine; eGFR Estimated glomerular filtration rate; ACR Albumin-to-creatinine ratio
  2. Data are expressed as the mean ± standard deviation, median (interquartile range), or frequency (percentage).
  3. P values were calculated using one-way analysis of variance or non-parametric tests for continuous variables and the chi-square test for categorical variables.
  4. * Compared with the NWNT group, P < 0.05
  5. # Compared with the EWNT group, P < 0.05
  6. § Compared with the NWET group, P < 0.05